Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Diabetes and coronary disease: a need for new therapies for an expanding disease burden.

Lew WY, DeMaria AN.

J Am Coll Cardiol. 2013 May 21;61(20):2046-7. doi: 10.1016/j.jacc.2013.03.002. Epub 2013 Mar 10. No abstract available. Erratum in: J Am Coll Cardiol. 2013 Jul 16;62(3):260.

2.

In regard to the TERISA trial.

Golwala H.

J Am Coll Cardiol. 2014 Jul 29;64(4):420. doi: 10.1016/j.jacc.2013.05.108. No abstract available.

3.

Reply: In regard to the TERISA trial.

Kosiborod M, Arnold SV, Spertus JA, McGuire DK, Yue P, Ben-Yehuda O, Belardinelli L, Chaitman BR.

J Am Coll Cardiol. 2014 Jul 29;64(4):420-1. doi: 10.1016/j.jacc.2013.07.122. No abstract available.

4.

Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina).

Kosiborod M, Arnold SV, Spertus JA, McGuire DK, Li Y, Yue P, Ben-Yehuda O, Katz A, Jones PG, Olmsted A, Belardinelli L, Chaitman BR.

J Am Coll Cardiol. 2013 May 21;61(20):2038-45. doi: 10.1016/j.jacc.2013.02.011. Epub 2013 Mar 10.

5.

Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina.

Arnold SV, Kosiborod M, McGuire DK, Li Y, Yue P, Ben-Yehuda O, Spertus JA.

JAMA Intern Med. 2014 Aug;174(8):1403-5. doi: 10.1001/jamainternmed.2014.2120. No abstract available.

PMID:
24887304
6.

Update on evidence for treatment with ranolazine in stable angina.

Carbone F, Montecucco F, Mach F.

Swiss Med Wkly. 2013 Oct 25;143:w13874. doi: 10.4414/smw.2013.13874. Review.

7.

Efficacy and safety of ranolazine in patients with chronic stable angina.

Kloner RA, Hines ME, Geunes-Boyer S.

Postgrad Med. 2013 Nov;125(6):43-52. doi: 10.3810/pgm.2013.11.2711. Review.

PMID:
24200760
8.

[Symptomatic coronary heart disease therapy: ranolazine reduces frequency of angina in diabetic patients].

[No authors listed]

MMW Fortschr Med. 2013 Mar 28;155 Spec No 1(1):20. German. No abstract available.

PMID:
24260912
9.

[Ranolazine in the treatment of chronic stable angina].

Gustapane M, Cardillo MT, Biasillo G, Della Bona R.

Clin Ter. 2012;163(3):231-4. Review. Italian.

PMID:
22964698
10.

[The TERISA study].

Galderisi M, Mafrici A.

G Ital Cardiol (Rome). 2013 Dec;14(12):797-802. doi: 10.1714/1371.15235. Italian. No abstract available.

PMID:
24336594
11.
12.

Management of myocardial ischemia. Is ranolazine needed? For all or some patients with myocardial ischemia?

Cocco G.

Expert Opin Pharmacother. 2012 Dec;13(17):2429-32. doi: 10.1517/14656566.2012.741592. Epub 2012 Nov 4.

PMID:
23121536
13.

Inhibition of sodium-dependent calcium overload to treat myocardial ischemia.

Conti CR.

Clin Cardiol. 2006 Apr;29(4):141-3. Review. Erratum in: Clin Cardiol. 2006 Jun;29(6):276.

14.

Late sodium current inhibition as a new cardioprotective approach.

Hale SL, Shryock JC, Belardinelli L, Sweeney M, Kloner RA.

J Mol Cell Cardiol. 2008 Jun;44(6):954-67. doi: 10.1016/j.yjmcc.2008.03.019. Epub 2008 Apr 8. Review.

PMID:
18462746
15.

The patient with chronic ischemic heart disease. Role of ranolazine in the management of stable angina.

Di Monaco A, Sestito A.

Eur Rev Med Pharmacol Sci. 2012 Nov;16(12):1611-36. Review.

16.

Expanding the understanding of the treatment of chronic angina: a 21st century approach--part 1.

Conti CR.

Clin Cardiol. 2008 Jun;31(6):239-40. doi: 10.1002/clc.20402. No abstract available.

17.

Evaluative framework for phase II studies in patients with heart failure and preserved ejection fraction.

Gheorghiade M, Vaduganathan M, Shah SJ.

JACC Heart Fail. 2013 Apr;1(2):123-6. doi: 10.1016/j.jchf.2013.01.001. Epub 2013 Apr 1. No abstract available.

PMID:
24621837
18.

Ranolazine--a nicely timed new medical therapy for stable angina.

Jackson G.

Int J Clin Pract. 2007 Jul;61(7):1063. No abstract available.

PMID:
17577287
19.

Expanding the understanding of the treatment of chronic angina: a 21st century approach-part II.

Conti CR.

Clin Cardiol. 2008 Jul;31(7):295-6. doi: 10.1002/clc.20406.

20.

Ranolazine: a novel agent that improves dysfunctional sodium channels.

Pham DQ, Mehta M.

Int J Clin Pract. 2007 May;61(5):864-72. Review.

PMID:
17493093

Supplemental Content

Support Center